Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Christine S Ho"'
Autor:
April C, Pettit, Jason E, Stout, Robert, Belknap, Constance A, Benson, Marie Nancy, Séraphin, Michael, Lauzardo, David J, Horne, Richard S, Garfein, Fernanda, Maruri, Christine S, Ho, Thaddeus, Miller
Publikováno v:
Clinical Infectious Diseases. 73:e2278-e2284
Background Increased risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB) disease among people living with human immunodeficiency virus (HIV; PLWH) prioritizes them for LTBI testing and treatment. Studies comparing the p
Autor:
Christine S Ho, Pei-Jean Feng, Masahiro Narita, Jason E Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J Katz
Publikováno v:
The Lancet. Infectious diseases. 22(2)
Autor:
Christine S Ho, Pei-Jean I Feng, Masahiro Narita, Jason E Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J Katz, Jennifer Flood, Julie Higashi, Kathleen Moser, Marisa Moore, Constance Benson, Robert Belknap, Jason E. Stout, Amina Ahmed, Timothy Sterling, April Pettit, Henry M. Blumberg, Alawode Oladele, Michael Lauzardo, Marie N. Seraphin, Richard Brostrom, Renuka Khurana, Wendy Cronin, Susan Dorman, David Horne, Thaddeus Miller
Publikováno v:
Lancet Infect Dis
BACKGROUND: Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e933412283cfc14021bf1b6a2b52ce
https://europepmc.org/articles/PMC8712384/
https://europepmc.org/articles/PMC8712384/
Autor:
Randall Reves, Pei-Jean Feng, Andrew Christian Whelen, Angela Largen, Christine S Ho, Niaz Banaei, Yanjue Wu, Robert Belknap, Richard Brostrom, Adithya Cattamanchi, Lance Chinna
Publikováno v:
Journal of Clinical Microbiology. 59
T-SPOT®.TB (T-SPOT) is an interferon-gamma release assay (IGRA) used to detect infection with Mycobacterium tuberculosis based on the number of spot-forming T-cells; however, delays in sample processing have been shown to reduce the number of these
Autor:
Pei-Jean, Feng, Yanjue, Wu, Christine S, Ho, Lance, Chinna, Andrew Christian, Whelen, Angela, Largen, Richard, Brostrom, Randall, Reves, Robert, Belknap, Adithya, Cattamanchi, Niaz, Banaei
Publikováno v:
J Clin Microbiol
T-SPOT.TB (T-SPOT) is an interferon gamma release assay (IGRA) used to detect infection with Mycobacterium tuberculosis based on the number of spot-forming T cells; however, delays in sample processing have been shown to reduce the number of these sp
Autor:
Tracy Ayers, Dolly J. Katz, Christine S Ho, Kathryn Winglee, Andrew N. Hill, Henry M. Blumberg, Jeffrey M. Collins, Jason E. Stout
Publikováno v:
Clin Infect Dis
BackgroundMost tuberculosis (TB) disease in the United States (US) is attributed to reactivation of remotely acquired latent TB infection (LTBI) in non-US-born persons who were likely infected with Mycobacterium tuberculosis in their countries of bir
Publikováno v:
Clin Infect Dis
We analyzed data from 2012 to 2016 for patients who were hospitalized or who died after ≥1 dose of isoniazid-rifapentine for treatment of latent Mycobacterium tuberculosis infection. No patients died; 15 were hospitalized. Nine patients experienced
Autor:
Shu-Hua Wang, Christine S Ho, Garrett W Hunt, Brock Stewart, Leonard Mukasa, Amy L. Sandul, Ruth N. Moro, Phil Griffin, Neha Shah, J Mike Holcombe, Asween Marco, Sapna Bamrah-Morris, Naveen Patil, Nwabunie Nwana, John A. Jereb, Suzanne M. Marks, Mark N. Lobato, Risa M. Webb, Terence Chorba, Sundari Mase
Publikováno v:
Clinical Infectious Diseases. 65:1085-1093
Background Randomized controlled trials have demonstrated that the newest latent tuberculosis (LTBI) regimen, 12 weekly doses of directly observed isoniazid and rifapentine (3HP), is as efficacious as 9 months of isoniazid, with a greater completion
Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection
Autor:
Thara Venkatappa, Edward A. Graviss, Niaz Banaei, Robert Belknap, Christine S Ho, Michael P. Higgins, Rose Punnoose, Dolly J. Katz
The fourth-generation QuantiFERON test for tuberculosis infection, QuantiFERON-TB Gold Plus (QFT-Plus) has replaced the earlier version, QuantiFERON-TB Gold In-Tube (QFT-GIT). A clinical need exists for information about agreement between QFT-Plus an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205bdda767dce6cf642081adb3a1f97e
https://europepmc.org/articles/PMC6813010/
https://europepmc.org/articles/PMC6813010/
Autor:
Pei-Jean Feng, Christine S Ho, Susan Marantz, Dolly J. Katz, Supriya Jasuja, C. Robert Horsburgh, Baby M. Djojonegoro, Elizabeth Fair, Lauren A. Lambert
Publikováno v:
Microbiology Insights, Vol 11 (2018)
Microbiology Insights
Microbiology Insights
Objective: The aim of this study is to assess whether choice of test for tuberculosis (TB) infection affects decisions to accept and complete treatment among contacts to TB cases. Methods: Retrospective study is conducted in which TB contacts, ⩾15